Category: Include on Menu

  • ZenaTech Advances IQ Octo Precision Agriculture Drone to Prototype Testing Stage

    ZenaTech Advances IQ Octo Precision Agriculture Drone to Prototype Testing Stage

    The autonomous spraying and seeding drone is expected to begin field testing in Arizona within weeks, expanding ZenaTech Inc.’s (NASDAQ:ZENA) Drone as a Service strategy into precision agriculture applications. Key Investor Takeaways Why ZENA Stock Is in Focus ZenaDrone has completed the first prototype of IQ Octo, moving its purpose-built precision agriculture drone toward field…

  • Medical Care Technologies Prepares First StrainScan Pro Enterprise Agricultural Demos

    Medical Care Technologies Prepares First StrainScan Pro Enterprise Agricultural Demos

    The move brings Medical Care Technologies Inc. (USOTC:MDCE) closer to direct enterprise evaluation of its AI vision platform, although the company stressed that the demonstrations do not represent commercial contracts. Key Investor Takeaways Why MDCE Stock Is in Focus Medical Care Technologies is moving StrainScan Pro from market positioning into live demonstrations tailored for enterprise…

  • Palantir Expands PwC Strategic Alliance to Scale Enterprise AI Across Core Business Operations

    Palantir Expands PwC Strategic Alliance to Scale Enterprise AI Across Core Business Operations

    The expanded collaboration targets enterprise AI deployment, M&A transformation and ERP modernization, giving Palantir Technologies Inc. (NASDAQ:PLTR) a broader route for embedding its platforms into complex corporate workflows. Key Investor Takeaways Why PLTR Stock Is in Focus Palantir and PwC are broadening their relationship beyond individual AI deployments to address large-scale enterprise transformation projects. The…

  • Vivos Inc. Peer-Reviewed PrecisionGel Publication Strengthens Scientific Case for Drug Delivery Platform

    Vivos Inc. Peer-Reviewed PrecisionGel Publication Strengthens Scientific Case for Drug Delivery Platform

    The Elsevier journal publication characterizes PrecisionGel’s biomolecular release properties, adding peer-reviewed support for Vivos Inc.’s (USOTC:RDGL) clinical, regulatory and potential licensing efforts. Key Investor Takeaways Why RDGL Stock Is in Focus The peer-reviewed PrecisionGel publication gives investors a new external scientific reference point for a technology that sits at the center of Vivos’ therapeutic platform.…

  • Nano Nuclear Advances KRONOS Helium Circulator to Detailed Design Phase

    Nano Nuclear Advances KRONOS Helium Circulator to Detailed Design Phase

    Nano Nuclear Energy (NASDAQ:NNE) said its engineering collaboration with Howden, a Baker Hughes business, has progressed to the detailed design phase for the primary helium circulator of its KRONOS MMR™ Energy System. The helium circulator is a mechanical subsystem designed to move helium coolant through the reactor core to transfer heat. Howden is leading the…

  • Kala Bio Signs Exclusive U.S. Distribution Agreement for Virotek Ophthalmology Genetic Tests

    Kala Bio Signs Exclusive U.S. Distribution Agreement for Virotek Ophthalmology Genetic Tests

    Kala Bio, Inc. (NASDAQ:KALA) and Virotek Inc. have finalised an exclusive distribution and reseller agreement covering Virotek’s ophthalmology genomic testing and screening programme in the United States. Under the agreement, which took effect on September 4, 2026, Kala will serve as the sole U.S. distributor of the programme and will have the right to market,…

  • Advasa Holdings Shares Fall Following CFO Resignation

    Advasa Holdings Shares Fall Following CFO Resignation

    Advasa Holdings Inc (NASDAQ:ADBT) shares fell 11.6% in premarket trading on Thursday following the resignation of Chief Financial Officer Katharyn Field. According to an 8-K filing with securities regulators, Field formally resigned from her position on August 27, 2026. The company said Field’s departure was for personal reasons and was not related to any dispute…

  • Envista Holdings Shares Rise After JPMorgan Upgrade

    Envista Holdings Shares Rise After JPMorgan Upgrade

    Envista Holdings Corp. (NYSE:NVST) shares rose 2.3% in premarket trading on Thursday after JPMorgan upgraded the dental products company ahead of its September 17 Investor Day. JPMorgan analyst Lilia-Celine B Lozada raised Envista to Overweight from Neutral and increased the price target to $32 from $29. “Heading into Envista’s September 17th Investor Day, we are…

  • Ciena Shares Rise After Q3 Earnings and Revenue Exceed Estimates

    Ciena Shares Rise After Q3 Earnings and Revenue Exceed Estimates

    Ciena Corporation (NYSE:CIEN) shares rose 4.3% in premarket trading after the optical networking equipment company reported fiscal third-quarter earnings and revenue above analyst expectations. For the quarter ended August 1, 2026, Ciena reported adjusted earnings per share of $2.11, exceeding the analyst consensus of $1.72 by $0.39. Revenue increased 37% year over year to $1.67…

  • Climb Bio Shares Rise 17% After Phase 1 CLYM116 Trial Data

    Climb Bio Shares Rise 17% After Phase 1 CLYM116 Trial Data

    Climb Bio, Inc. (NASDAQ:CLYM) shares rose 17% on Thursday after the clinical-stage biotechnology company released Phase 1 trial data for CLYM116, its anti-APRIL monoclonal antibody being developed for IgA nephropathy. The company reported that a single 320 mg dose of CLYM116 resulted in near-complete APRIL suppression and 60% to 75% suppression of IgA/Gd-IgA1 through 12…